There were 816 press releases posted in the last 24 hours and 442,476 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
HOOKIPA Announces First Patient Dosed in Phase 1/2 Clinical Trial for HB-201 for the Treatment of Human Papillomavirus 16-Positive Cancers

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image